116 related articles for article (PubMed ID: 15537904)
21. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
[No Abstract] [Full Text] [Related]
22. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?
Hollander D
Am J Gastroenterol; 2002 Aug; 97(8):1867-8. PubMed ID: 12190145
[No Abstract] [Full Text] [Related]
23. Summaries for patients. Treatment of Crohn disease with anti-tumor necrosis factor agent.
Ann Intern Med; 2007 Jun; 146(12):I20. PubMed ID: 17470825
[No Abstract] [Full Text] [Related]
24. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases].
Wittig BM; Zeitz M
Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615
[No Abstract] [Full Text] [Related]
25. Cytokine therapy for Crohn's disease: advances in translational research.
Pizarro TT; Cominelli F
Annu Rev Med; 2007; 58():433-44. PubMed ID: 17217333
[TBL] [Abstract][Full Text] [Related]
26. Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor.
Boscá MM; Pérez-Baylach CM; Solis MA; Antón R; Mayordomo E; Pons S; Mínguez M; Benages A
Gut; 2006 Feb; 55(2):294-5. PubMed ID: 16407390
[No Abstract] [Full Text] [Related]
27. Cytokine-target therapies cost effective in Crohn's disease?
McClellan K
Drugs R D; 1999 Mar; 1(3):273-4. PubMed ID: 10566045
[No Abstract] [Full Text] [Related]
28. Natalizumab for active Crohn's disease.
Lew EA; Stoffel EM
N Engl J Med; 2003 Apr; 348(16):1599; author reply 1599. PubMed ID: 12700383
[No Abstract] [Full Text] [Related]
29. Crohn's disease: beyond antagonists of tumour necrosis factor.
Peyrin-Biroulet L; Desreumaux P; Sandborn WJ; Colombel JF
Lancet; 2008 Jul; 372(9632):67-81. PubMed ID: 18603161
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Crohn's disease--the new era.
Jewell DP
Dig Liver Dis; 2002 Oct; 34(10):689-91. PubMed ID: 12469794
[No Abstract] [Full Text] [Related]
31. Biological response modifiers for the treatment of Crohn's disease.
Siveke JT; Folwaczny C
Expert Opin Biol Ther; 2004 Nov; 4(11):1719-27. PubMed ID: 15500400
[TBL] [Abstract][Full Text] [Related]
32. Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: pro. Why use steroids if safer therapies are available?
Baldassano RN
Inflamm Bowel Dis; 2001 Nov; 7(4):338-41; discussion 345-6. PubMed ID: 11720326
[No Abstract] [Full Text] [Related]
33. Early combined immunosuppression in Crohn's disease.
Danese S; Peyrin-Biroulet L
Lancet; 2008 Jun; 371(9629):1996; author reply 1996-7. PubMed ID: 18555908
[No Abstract] [Full Text] [Related]
34. Anti-TNF antibody treatment of Crohn's disease.
van Deventer SJ
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I114-20. PubMed ID: 10577987
[No Abstract] [Full Text] [Related]
35. Proinflammatory cytokines underlying the inflammation of Crohn's disease.
Strober W; Zhang F; Kitani A; Fuss I; Fichtner-Feigl S
Curr Opin Gastroenterol; 2010 Jul; 26(4):310-7. PubMed ID: 20473158
[TBL] [Abstract][Full Text] [Related]
36. Tumour necrosis factor and Crohn's disease.
Van Deventer SJ
Gut; 1997 Apr; 40(4):443-8. PubMed ID: 9176068
[No Abstract] [Full Text] [Related]
37. Oxpentifylline, tumour necrosis factor-alpha and Crohn's disease.
MacDonald TT
Gut; 1997 Apr; 40(4):559. PubMed ID: 9176092
[No Abstract] [Full Text] [Related]
38. Risankizumab for Induction and Maintenance of Remission in Crohn's Disease.
Khanna R
Gastroenterology; 2022 Nov; 163(5):1470-1471. PubMed ID: 35961380
[No Abstract] [Full Text] [Related]
39. Esophagogastric Crohn's Disease Manifested by Life-Threatening Odynophagia and Chest Pain: a Case Report.
So H; Park BH; Jang K; Baek H; Kim YJ
J Korean Med Sci; 2018 Jan; 33(4):e30. PubMed ID: 29318797
[No Abstract] [Full Text] [Related]
40. In active Crohn disease, risankizumab increased clinical remission and endoscopic response at 12 wk.
Oliver D; Talley NJ
Ann Intern Med; 2022 Oct; 175(10):JC114. PubMed ID: 36191314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]